Meghmani Organics Share Price
Sector: Chemical Manufacturing
79.59 -1.01 (-1.25%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
78.91
Today’s High
81.20
52 Week Low
57
52 Week High
116
80.52 -0.14 (-0.17%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
80.41
Today’s High
81.43
52 Week Low
56.11
52 Week High
115.95
Key Metrics
- Market Cap (In Cr) 2024.09
- Beta 0.91
- Div. Yield (%) 0
- P/B 1.35
- TTM P/E -
- Peg Ratio -
- Sector P/E 17.07
- D/E 0.01
- Open Price 81
- Prev Close 80.6
Meghmani Organics Analysis
Price Analysis
-
1 Week7.78%
-
3 Months9.12%
-
6 Month-14.65%
-
YTD4.81%
-
1 Year-2.82%
Risk Meter
- 47% Low risk
- 47% Moderate risk
- 47% Balanced Risk
- 47% High risk
- 47% Extreme risk
Meghmani Organics News
Stocks to buy under ₹100: Experts recommend six shares to buy today — 18 Feb
2 min read . 18 Feb 2025Stocks to buy under ₹100: Experts recommend six intraday stocks for today
2 min read . 10 Jan 2025Small-cap stocks under ₹100: Experts recommend six shares to buy on Monday
3 min read . 28 Dec 2024Meghmani Organics Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 2079.75
- Selling/ General/ Admin Expenses Total
- 114.37
- Depreciation/ Amortization
- 108.13
- Other Operating Expenses Total
- 558.75
- Total Operating Expense
- 2045.13
- Operating Income
- 34.61
- Net Income Before Taxes
- 9.47
- Net Income
- -10.6
- Diluted Normalized EPS
- -0.42
- Period
- 2025
- Total Assets
- 3085.41
- Total Liabilities
- 1570.15
- Total Equity
- 1515.26
- Tangible Book Valueper Share Common Eq
- 58.91
- Period
- 2025
- Cashfrom Operating Activities
- 66.22
- Cashfrom Investing Activities
- 30.97
- Cashfrom Financing Activities
- -91.39
- Net Changein Cash
- 5.8
- Period
- 2024
- Total Revenue
- 1566.28
- Selling/ General/ Admin Expenses Total
- 262.19
- Depreciation/ Amortization
- 92.22
- Other Operating Expenses Total
- 66.11
- Total Operating Expense
- 1676.88
- Operating Income
- -110.6
- Net Income Before Taxes
- -121.18
- Net Income
- -106.03
- Diluted Normalized EPS
- -4.15
- Period
- 2024
- Total Assets
- 3038.56
- Total Liabilities
- 1510.87
- Total Equity
- 1527.69
- Tangible Book Valueper Share Common Eq
- 59.52
- Period
- 2024
- Cashfrom Operating Activities
- 249.68
- Cashfrom Investing Activities
- -178.38
- Cashfrom Financing Activities
- -85.48
- Net Changein Cash
- -14.18
- Period
- 2023
- Total Revenue
- 2552.62
- Selling/ General/ Admin Expenses Total
- 512.76
- Depreciation/ Amortization
- 77.06
- Other Operating Expenses Total
- 74.24
- Total Operating Expense
- 2268.41
- Operating Income
- 284.22
- Net Income Before Taxes
- 313.09
- Net Income
- 237.71
- Diluted Normalized EPS
- 8.8
- Period
- 2023
- Total Assets
- 3198.44
- Total Liabilities
- 1529.22
- Total Equity
- 1669.23
- Tangible Book Valueper Share Common Eq
- 65.17
- Period
- 2023
- Cashfrom Operating Activities
- 204.47
- Cashfrom Investing Activities
- -417.64
- Cashfrom Financing Activities
- 233.73
- Net Changein Cash
- 20.57
- Period
- 2022
- Total Revenue
- 2498.46
- Selling/ General/ Admin Expenses Total
- 309.16
- Depreciation/ Amortization
- 62.65
- Other Operating Expenses Total
- 63.41
- Total Operating Expense
- 2155.03
- Operating Income
- 343.43
- Net Income Before Taxes
- 408.8
- Net Income
- 304.42
- Diluted Normalized EPS
- 11.81
- Period
- 2022
- Total Assets
- 2797.61
- Total Liabilities
- 1331.39
- Total Equity
- 1466.22
- Tangible Book Valueper Share Common Eq
- 57.22
- Period
- 2022
- Cashfrom Operating Activities
- 65
- Cashfrom Investing Activities
- -132.94
- Cashfrom Financing Activities
- 57.72
- Net Changein Cash
- -10.23
- Period
- 2021
- Total Revenue
- 1636.66
- Selling/ General/ Admin Expenses Total
- 243.99
- Depreciation/ Amortization
- 50.68
- Other Operating Expenses Total
- 47.53
- Total Operating Expense
- 1395.99
- Operating Income
- 240.66
- Net Income Before Taxes
- 251.8
- Net Income
- 186.48
- Diluted Normalized EPS
- 7.17
- Period
- 2021
- Total Assets
- 1974.15
- Total Liabilities
- 801.12
- Total Equity
- 1173.03
- Tangible Book Valueper Share Common Eq
- 45.69
- Period
- 2021
- Cashfrom Operating Activities
- 333.39
- Cashfrom Investing Activities
- -306.93
- Cashfrom Financing Activities
- -14.24
- Net Changein Cash
- 12.22
- Period
- 2020
- Total Revenue
- 2191.18
- Selling/ General/ Admin Expenses Total
- 282.4
- Depreciation/ Amortization
- 88.59
- Other Operating Expenses Total
- 55.18
- Total Operating Expense
- 1843.67
- Operating Income
- 347.51
- Net Income Before Taxes
- 359.04
- Net Income
- 240.15
- Diluted Normalized EPS
- 9.49
- Period
- 2020
- Total Assets
- 2736.92
- Total Liabilities
- 1527.86
- Total Equity
- 1209.06
- Tangible Book Valueper Share Common Eq
- 46.58
- Period
- 2020
- Cashfrom Operating Activities
- 404.28
- Cashfrom Investing Activities
- -480.8
- Cashfrom Financing Activities
- -48.18
- Net Changein Cash
- -124.71
- Period
- 2019
- Total Revenue
- 2087.96
- Selling/ General/ Admin Expenses Total
- 296.42
- Depreciation/ Amortization
- 97.26
- Other Operating Expenses Total
- 49.28
- Total Operating Expense
- 1633.75
- Operating Income
- 454.21
- Net Income Before Taxes
- 408.56
- Net Income
- 251.27
- Diluted Normalized EPS
- 10.44
- Period
- 2019
- Total Assets
- 2376.76
- Total Liabilities
- 1373.16
- Total Equity
- 1003.6
- Tangible Book Valueper Share Common Eq
- 38.82
- Period
- 2019
- Cashfrom Operating Activities
- 375.23
- Cashfrom Investing Activities
- -291.3
- Cashfrom Financing Activities
- 45.11
- Net Changein Cash
- 129.04
- Period
- 2025-03-31
- Total Revenue
- 553.46
- Selling/ General/ Admin Expenses Total
- 29.7
- Depreciation/ Amortization
- 29.49
- Other Operating Expenses Total
- 146.55
- Total Operating Expense
- 517.47
- Operating Income
- 35.99
- Net Income Before Taxes
- 30.55
- Net Income
- 19.82
- Diluted Normalized EPS
- 0.78
- Period
- 2025-03-31
- Total Assets
- 3085.41
- Total Liabilities
- 1570.15
- Total Equity
- 1515.26
- Tangible Book Valueper Share Common Eq
- 58.91
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 66.22
- Cashfrom Investing Activities
- 30.97
- Cashfrom Financing Activities
- -91.39
- Net Changein Cash
- 5.8
- Period
- 2024-12-31
- Total Revenue
- 568.51
- Selling/ General/ Admin Expenses Total
- 28.2
- Depreciation/ Amortization
- 29.67
- Other Operating Expenses Total
- 154.8
- Total Operating Expense
- 557.35
- Operating Income
- 11.16
- Net Income Before Taxes
- 7.41
- Net Income
- -4.39
- Diluted Normalized EPS
- -0.17
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 543.89
- Selling/ General/ Admin Expenses Total
- 28.65
- Depreciation/ Amortization
- 25.49
- Other Operating Expenses Total
- 139.96
- Total Operating Expense
- 538.81
- Operating Income
- 5.08
- Net Income Before Taxes
- -9.17
- Net Income
- -9.27
- Diluted Normalized EPS
- -0.36
- Period
- 2024-09-30
- Total Assets
- 3193.84
- Total Liabilities
- 1694.55
- Total Equity
- 1499.29
- Tangible Book Valueper Share Common Eq
- 58.35
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 84.73
- Cashfrom Investing Activities
- -3.7
- Cashfrom Financing Activities
- -74.75
- Net Changein Cash
- 6.28
- Period
- 2024-06-30
- Total Revenue
- 413.88
- Selling/ General/ Admin Expenses Total
- 27.82
- Depreciation/ Amortization
- 23.48
- Other Operating Expenses Total
- 117.44
- Total Operating Expense
- 431.5
- Operating Income
- -17.62
- Net Income Before Taxes
- -19.32
- Net Income
- -16.76
- Diluted Normalized EPS
- -0.66
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 410.03
- Selling/ General/ Admin Expenses Total
- 28.64
- Depreciation/ Amortization
- 22.8
- Other Operating Expenses Total
- 129.44
- Total Operating Expense
- 430.81
- Operating Income
- -20.77
- Net Income Before Taxes
- -14.32
- Net Income
- -17.96
- Diluted Normalized EPS
- -0.71
- Period
- 2024-03-31
- Total Assets
- 3038.56
- Total Liabilities
- 1510.87
- Total Equity
- 1527.69
- Tangible Book Valueper Share Common Eq
- 59.52
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 249.68
- Cashfrom Investing Activities
- -178.38
- Cashfrom Financing Activities
- -85.48
- Net Changein Cash
- -14.18
- Period
- 2023-12-31
- Total Revenue
- 351.75
- Selling/ General/ Admin Expenses Total
- 27.78
- Depreciation/ Amortization
- 23.13
- Other Operating Expenses Total
- 100.88
- Total Operating Expense
- 382.68
- Operating Income
- -30.93
- Net Income Before Taxes
- -47.94
- Net Income
- -38.23
- Diluted Normalized EPS
- -1.5
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Meghmani Organics Technical
Moving Average
SMA
- 5 Day77.74
- 10 Day74.04
- 20 Day72.97
- 50 Day68.61
- 100 Day72.88
- 300 Day85.41
Meghmani Organics Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Insecticides India
- 754.85
- -5.85
- -0.77
- 1084.65
- 475.5
- 2196.45
- Yasho Industries
- 1744.7
- 0.55
- 0.03
- 2330
- 1600.1
- 2103.6
- Meghmani Organics
- 79.59
- -1.01
- -1.25
- 116
- 57
- 2024.09
- India Pesticides
- 170.6
- -0.55
- -0.32
- 263.85
- 119.85
- 1973.56
- Tatva Chintan Pharma Chem
- 800
- 43.4
- 5.74
- 1211
- 610
- 1870.15
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Insecticides India
- 22.09
- 2.2
- 10.86
- 5.63
- Yasho Industries
- 326.24
- 4.99
- 20.1
- 7.08
- Meghmani Organics
- -
- 1.34
- 8.5
- 5.92
- India Pesticides
- 31.88
- 2.32
- -
- -
- Tatva Chintan Pharma Chem
- 315.16
- 2.43
- 9.9
- 11.88
Meghmani Organics Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 10-May-25
- Audited Results
- 08-Feb-25
- Quarterly Results
- 26-Oct-24
- Quarterly Results
- 27-Jul-24
- Quarterly Results
- 11-May-24
- Audited Results
- 30-Jan-24
- Quarterly Results
- 07-Nov-23
- Quarterly Results
- 14-Aug-23
- Quarterly Results
- 29-Apr-23
- Audited Results & Final Dividend
- 21-Jan-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 09-Jul-24
- 18-Jun-24
- AGM
- 12-Dec-23
- 13-Nov-23
- POM
- 23-Sept-23
- 22-Aug-23
- POM
- 27-Jun-23
- 29-Apr-23
- AGM
- 27-Jun-22
- 02-May-22
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 02-May-23
- 20-Jun-23
- 20-Jun-23
- 1.4
- 02-May-22
- 20-Jun-22
- 17-Jun-22
- 1.4
- 13-Sept-21
- -
- 15-Sept-21
- 1.4


